On July 6, 2018 the FDA released an industry guidance document for transitioning from individual to pooled ZIKV testing. Additionally, on July 5th Grifols received licensure for their NAT ZIKV test for both individual and pooled donations.
Check out the Communication page for the complete details on the NAT ZIKV test or by clicking the link: Communications
The new online Learning Center with new content can still be found under the “Training” folder on ...
FDA Guidance titled “Further Testing of Donations that are Reactive on a Licensed Donor Screen...
This is the first update to the original CTS communication distributed on July 6th. As previously co...
Just a reminder that the revised client forms implement today! Don't forget to toss your o...
We are informing you that the FDA has announced their withdrawal of Guidance for ZIKV Testing. In th...
The recent communication regarding the recent Anti-SARS-CoV-2 Total assay in Tampa has brought about...